IE892367L - Selectively o-acylated glycosaminoglycans, their preparation¹and pharmaceutical compositions containing them - Google Patents

Selectively o-acylated glycosaminoglycans, their preparation¹and pharmaceutical compositions containing them

Info

Publication number
IE892367L
IE892367L IE892367A IE236789A IE892367L IE 892367 L IE892367 L IE 892367L IE 892367 A IE892367 A IE 892367A IE 236789 A IE236789 A IE 236789A IE 892367 L IE892367 L IE 892367L
Authority
IE
Ireland
Prior art keywords
selectively
pharmaceutical compositions
compositions containing
glycosaminoglycans
acylated
Prior art date
Application number
IE892367A
Original Assignee
Synthetic Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Ind Ltd filed Critical Synthetic Ind Ltd
Publication of IE892367L publication Critical patent/IE892367L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The glycosaminoglycans of the invention are selectively O-acylated in a controllable manner on their free -OH groups, the carboxylic or amino functional groups being unaltered. These compounds have a pharmacological activity of very long duration.
IE892367A 1988-07-21 1989-07-21 Selectively o-acylated glycosaminoglycans, their preparation¹and pharmaceutical compositions containing them IE892367L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809885A FR2634485B1 (en) 1988-07-21 1988-07-21 SELECTIVELY O-ACYLATED GLYCOSAMINOGLYCANS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (1)

Publication Number Publication Date
IE892367L true IE892367L (en) 1990-01-21

Family

ID=9368648

Family Applications (1)

Application Number Title Priority Date Filing Date
IE892367A IE892367L (en) 1988-07-21 1989-07-21 Selectively o-acylated glycosaminoglycans, their preparation¹and pharmaceutical compositions containing them

Country Status (23)

Country Link
EP (1) EP0356275B1 (en)
JP (1) JPH0273801A (en)
KR (1) KR910002889A (en)
AT (1) ATE108804T1 (en)
AU (1) AU620632B2 (en)
DD (1) DD285606A5 (en)
DE (1) DE68916878T2 (en)
DK (1) DK362789A (en)
ES (1) ES2056239T3 (en)
FI (1) FI893518A (en)
FR (1) FR2634485B1 (en)
HU (1) HU206222B (en)
IE (1) IE892367L (en)
IL (1) IL91058A0 (en)
MA (1) MA21602A1 (en)
NO (1) NO892986L (en)
NZ (1) NZ230041A (en)
OA (1) OA09125A (en)
PT (1) PT91249B (en)
RU (1) RU1831487C (en)
TN (1) TNSN89082A1 (en)
YU (1) YU172789A (en)
ZA (1) ZA895581B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669932B1 (en) * 1990-12-03 1994-07-01 Sanofi Sa NOVEL HEPAROSANE-N, O-SULFATE, ITS PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
US5990095A (en) 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5834444A (en) * 1991-07-03 1998-11-10 Hyal Pharmaceutical Corporation Hyaluronic acid and salts thereof inhibit arterial restenosis
US5498775A (en) * 1994-11-07 1996-03-12 American Home Products Corporation Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
US5565432A (en) * 1994-11-07 1996-10-15 American Home Products Corporation Smooth muscle cell proliferation inhibitors
IL115745A (en) * 1994-11-07 2000-11-21 American Home Prod Acylated benzylglycosides and pharmaceutical compositions containing them
IT1286510B1 (en) * 1996-11-29 1998-07-15 Cooperativa Centro Ricerche Po BUTYRIC ESTERS WITH ANTI-PROLIFERATIVE ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
US6339064B1 (en) 1998-11-24 2002-01-15 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6362170B1 (en) 1998-11-24 2002-03-26 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US7132402B2 (en) 1998-11-24 2006-11-07 Wyeth Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6664243B1 (en) 1998-11-24 2003-12-16 Wyeth Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US6340670B1 (en) 1998-11-24 2002-01-22 American Home Products Corporation Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6258784B1 (en) 1998-11-24 2001-07-10 American Home Products Corp. Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
US7081448B2 (en) 1998-11-24 2006-07-25 Wyeth Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
CA2317305A1 (en) 2000-08-29 2002-02-28 Tassos P. Anastassiades Method of enhancing chondrocyte cell growth and glycosaminoglycan production
KR20030057040A (en) * 2001-12-28 2003-07-04 주식회사 효성 D-Glucosamine derivatives and Method for Preparing Thereof
KR100790007B1 (en) * 2006-12-28 2008-01-02 경상대학교산학협력단 A method for purification glycosaminoglycans from ascidian tunic
JPWO2012036152A1 (en) * 2010-09-14 2014-02-03 国立大学法人 宮崎大学 High purity heparin and method for producing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3066M (en) * 1963-08-07 1965-01-18 Roussel Uclaf New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
JPS469327B1 (en) * 1966-03-31 1971-03-09
JPS52111983A (en) * 1976-03-18 1977-09-20 Teijin Ltd Preparation of heparin derivatives
US4331697A (en) * 1980-09-02 1982-05-25 Teijin Limited Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
FR2584728B1 (en) * 1985-07-12 1987-11-20 Choay Sa PROCESS FOR THE SULFATION OF GLYCOSAMINOGLYCANS AND THEIR FRAGMENTS
JP5410580B1 (en) * 2012-08-09 2014-02-05 日本特殊陶業株式会社 Wiring board

Also Published As

Publication number Publication date
AU3885689A (en) 1990-01-25
YU172789A (en) 1991-08-31
DK362789D0 (en) 1989-07-21
RU1831487C (en) 1993-07-30
DE68916878T2 (en) 1995-03-16
MA21602A1 (en) 1990-04-01
FR2634485A1 (en) 1990-01-26
FI893518A0 (en) 1989-07-21
JPH0273801A (en) 1990-03-13
HUT50489A (en) 1990-02-28
NO892986L (en) 1990-01-22
PT91249B (en) 1995-05-04
PT91249A (en) 1990-02-08
EP0356275B1 (en) 1994-07-20
NO892986D0 (en) 1989-07-20
ES2056239T3 (en) 1994-10-01
DK362789A (en) 1990-01-22
NZ230041A (en) 1991-09-25
FR2634485B1 (en) 1992-02-28
TNSN89082A1 (en) 1991-02-04
DE68916878D1 (en) 1994-08-25
ZA895581B (en) 1990-04-25
ATE108804T1 (en) 1994-08-15
DD285606A5 (en) 1990-12-19
HU206222B (en) 1992-09-28
OA09125A (en) 1991-10-31
AU620632B2 (en) 1992-02-20
KR910002889A (en) 1991-02-26
IL91058A0 (en) 1990-02-09
FI893518A (en) 1990-01-22
EP0356275A1 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
IE892367L (en) Selectively o-acylated glycosaminoglycans, their preparation¹and pharmaceutical compositions containing them
GR3015232T3 (en) Angioplasty apparatus.
DE3887896D1 (en) ANGIOPLASTY ARRANGEMENT.
PH31205A (en) Pharmaceutical composition.
DE3762288D1 (en) SPRAYER NOZZLE.
DE3887261D1 (en) Urethane coating resin composition.
FI903759A0 (en) PHARMACEUTICAL COMPOSITION INNEHAOLLANDE N-ACETYLCYSTEIN FOER ORAL ADMINISTRERING.
DE68907595T2 (en) SPRAYING NOZZLES.
EP0620730A4 (en) Prolamine coatings for taste-masking orally-administrable medicaments.
GB2220756B (en) D.c biasing apparatus
ZA884858B (en) Tertiary 2,5-dialkyl-3-phenylpiperidine derivatives having opiate-antagonistic activity
DE3879871D1 (en) Elektrophotographische platte.
EP0300036A4 (en) Vasopressin-based pharmaceutical compositions.
ATE91438T1 (en) ATOMIZING NOZZLES.
IL82100A0 (en) Pharmaceutical composition containing 2,4,6-tris-tertiary-butyl-amino-1,3,5-triazine
IE880195L (en) 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones.
IE873354L (en) New pyrrolobenzimidazoles, processes for the preparation¹thereof and pharmaceutical compositions containing them.
GB8802062D0 (en) Track jointers
CS346189A3 (en) Solid material laser, particularly for angioplasty
CS473587A1 (en) Zpusob cisteni 1 amino 2,6 dimethylpiperidinu pripraveneho redukci 1 nitroso 2,6 dimethylpiperidinu
IE871940L (en) Controlled release pharmaceutical compositions.
FI884355A0 (en) CENTRERANDE BALLONRINGKONSTRUKTION FOER TRANSLUMINAL ANGIOPLASTIAKATETER.
IE870863L (en) 1,3,5-triazine derivatives
IT215377Z2 (en) PERFECTED TABLE FOR CHILDREN.
IE870862L (en) 1,3,5-triazines